UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain

The Journal of experimental medicine, 2018-05, Vol.215 (5), p.1301-1313

2018

Volltextzugriff (PDF)

Myeloid sarcoma without circulating leukemia mimicking gastrointestinal malignancy and lymphoma

Hematology reports, 2018-06, Vol.10 (2), p.7040-7040

2018

Volltextzugriff (PDF)

Strategies to Reduce Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

Current hematologic malignancy reports, 2013-06, Vol.8 (2), p.132-140

2013

Volltextzugriff (PDF)

Efficacy and Toxicity of Induction Therapy with Cladribine, Idarubicin, and Cytarabine (IAC) for Acute Myeloid Leukemia

Anticancer research, 2017-02, Vol.37 (2), p.713-717

2017

Volltextzugriff (PDF)

Acute myeloid leukemia induction with cladribine: Outcomes by age and leukemia risk

Leukemia research, 2018-05, Vol.68, p.72-78

2018

Volltextzugriff (PDF)

Gene expression changes in normal haematopoietic cells

Best practice & research. Clinical haematology, 2009-06, Vol.22 (2), p.249-269

2009

Volltextzugriff (PDF)

Tumor lysis syndrome and metastatic melanoma

Medical oncology (Northwood, London, England), 2016-12, Vol.33 (12), p.134, Article 134

2016

Volltextzugriff (PDF)

Strategies to Reduce Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

Current hematologic malignancy reports, 2013-06, Vol.8 (2), p.132-140

2013

Volltextzugriff (PDF)

Transformation of Myeloid Leukemia Cells to Cytokine Independence by Bcr-Abl Is Suppressed by Kinase-defective Hck

The Journal of biological chemistry, 2000-06, Vol.275 (24), p.18581-18585

2000

Volltextzugriff (PDF)

Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design

British journal of haematology, 2014-08, Vol.166 (3), p.375-381

2014

Volltextzugriff (PDF)

Hematopoietic cell transplant comorbidity index (HCT-CI) to assess AML induction risk

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e18519-e18519

2017

Volltextzugriff (PDF)

Detecting Accumulated Somatic Mutations in Healthy Aged Female Myeloid Cells

Blood, 2016-12, Vol.128 (22), p.5045-5045

2016

Volltextzugriff (PDF)

Quality Improvement Project: Workflow, Standardization and Data Validation of Comorbidity Index at a Small to Medium Volume Transplant Center

Biology of blood and marrow transplantation, 2017-03, Vol.23 (3), p.S416-S417

2017

Volltextzugriff (PDF)

Comparison of Processing Reagents (Hespan and PrepaCyte-CB®) in Preparation of Cord Blood Units at the Saint Louis Cord Blood Bank

Biology of blood and marrow transplantation, 2017-03, Vol.23 (3), p.S174-S175

2017

Volltextzugriff (PDF)

The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl

Cancer research (Chicago, Ill.), 2000-02, Vol.60 (4), p.1097-1103

2000

Volltextzugriff (PDF)

Quality Improvement Project: Pre-Transplant Disease Classification of Multiple Myeloma with Formal Data Validation Process at a Small to Medium Sized Transplant Center

Biology of blood and marrow transplantation, 2017-03, Vol.23 (3), p.S415-S415

2017

Volltextzugriff (PDF)

Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemia

Leukemia, 2014-10, Vol.28 (10), p.1969-1977

2014

Volltextzugriff (PDF)

Acute Myeloid Leukemia Induction with Cladribine: Effects of Age and Leukemia Risk

Blood, 2016-12, Vol.128 (22), p.3988-3988

2016

Volltextzugriff (PDF)

Novel Long-Term Co-Culture Approach Identifies Prognostically Important Heterogeneity Of Stem/Progenitor Cell Involvement In Human Acute Myeloid Leukemia

Blood, 2013-11, Vol.122 (21), p.1318-1318

2013

Volltextzugriff (PDF)

Advances in the management of patients with non-Hodgkin's lymphoma

Expert review of anticancer therapy, 2001-06, Vol.1 (1), p.43-52

2001

Volltextzugriff (PDF)

Innovative Phase I/II Statistical Design in Combination Chemotherapy That Combines Toxicity and Efficacy Parameters to Increase Study Efficiency: Bendamustine and Idarubicin in De Novo Adult AML

Blood, 2011-11, Vol.118 (21), p.1552-1552

2011

Volltextzugriff (PDF)

Survival After Failure of Initial Therapy for Newly-Diagnosed or Relapsed/Refractory AML At An Academic Center: Subsequent Clinical Trial Vs. Not

Blood, 2011-11, Vol.118 (21), p.1497-1497

2011

Volltextzugriff (PDF)

Safety and Efficacy of Bendamustine and Idarubicin in Combination Therapy for Patients Age ≥50 with Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome – Results From a Phase I/II Adaptive Design Study

Blood, 2012-11, Vol.120 (21), p.2622-2622

2012

Volltextzugriff (PDF)

Oligomerization of the Fes Tyrosine Kinase

The Journal of biological chemistry, 1997-07, Vol.272 (29), p.18498-18503

1997

Volltextzugriff (PDF)

478 - Quality Improvement Project: Workflow, Standardization and Data Validation of Comorbidity Index at a Small to Medium Volume Transplant Center

Biology of blood and marrow transplantation, 2017-03, Vol.23 (3), p.S416-S417

2017

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Humans
(12)
Hematology, Oncology And Palliative Medicine
(10)
Hematology
(8)
Oncology
(8)
Male
(6)
Acute Myeloid Leukemia
(5)
Female
(5)
Animals
(4)
Middle Aged
(4)
Adult
(3)
Aged
(3)
Biochemistry & Molecular Biology
(3)
Biological And Medical Sciences
(3)
Hematologic And Hematopoietic Diseases
(3)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(3)
Medical Sciences
(3)
Medicine
(3)
Proto-Oncogene Proteins C-Fes
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain

Myeloid sarcoma without circulating leukemia mimicking gastrointestinal malignancy and lymphoma

Strategies to Reduce Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

Efficacy and Toxicity of Induction Therapy with Cladribine, Idarubicin, and Cytarabine (IAC) for Acute Myeloid Leukemia

Acute myeloid leukemia induction with cladribine: Outcomes by age and leukemia risk

Gene expression changes in normal haematopoietic cells

Tumor lysis syndrome and metastatic melanoma

Strategies to Reduce Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

Transformation of Myeloid Leukemia Cells to Cytokine Independence by Bcr-Abl Is Suppressed by Kinase-defective Hck

Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design

Hematopoietic cell transplant comorbidity index (HCT-CI) to assess AML induction risk

Detecting Accumulated Somatic Mutations in Healthy Aged Female Myeloid Cells

Quality Improvement Project: Workflow, Standardization and Data Validation of Comorbidity Index at a Small to Medium Volume Transplant Center

Comparison of Processing Reagents (Hespan and PrepaCyte-CB®) in Preparation of Cord Blood Units at the Saint Louis Cord Blood Bank

The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl

Quality Improvement Project: Pre-Transplant Disease Classification of Multiple Myeloma with Formal Data Validation Process at a Small to Medium Sized Transplant Center

Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemia

Acute Myeloid Leukemia Induction with Cladribine: Effects of Age and Leukemia Risk

Novel Long-Term Co-Culture Approach Identifies Prognostically Important Heterogeneity Of Stem/Progenitor Cell Involvement In Human Acute Myeloid Leukemia

Advances in the management of patients with non-Hodgkin's lymphoma

Innovative Phase I/II Statistical Design in Combination Chemotherapy That Combines Toxicity and Efficacy Parameters to Increase Study Efficiency: Bendamustine and Idarubicin in De Novo Adult AML

Survival After Failure of Initial Therapy for Newly-Diagnosed or Relapsed/Refractory AML At An Academic Center: Subsequent Clinical Trial Vs. Not

Safety and Efficacy of Bendamustine and Idarubicin in Combination Therapy for Patients Age ≥50 with Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome – Results From a Phase I/II Adaptive Design Study

Oligomerization of the Fes Tyrosine Kinase

478 - Quality Improvement Project: Workflow, Standardization and Data Validation of Comorbidity Index at a Small to Medium Volume Transplant Center

Suchergebnisse filtern